A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine

NAActive, not recruitingINTERVENTIONAL

Enrollment

330

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Lung CancerHead and Neck Cancer

Interventions

OTHER

Fresh tissue biopsy

Fresh tissue biopsy will be collected.

OTHER

Blood/Urine Sample Collection

A one time blood sample will be collected.

Trial Locations (1)

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors

lead

University of Arkansas

OTHER

NCT02597738 - A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine | Biotech Hunter | Biotech Hunter